Also, GWAS performed on clinically diagnosed late-onset AD cases has reported a potential link between genetic variation in the gene that encodes GLP1 receptor and reduced risk to develop AD in these patients [317]. The gene discussed is GLP1R; the disease is Alzheimer disease.